A completely synthetic gene encoding the Hc domain of Clostridium botulinum neurotoxin serotype A (AHc,1287bp,429aa,~50kD) was constructed with oligonucleotides. After expressed in Escherichia coli,soluble product AHc was gained and verified by SDS-PAGE and Western blot analysis. The expressive level of recombinant AHc in E. coli was very high (36%~53% of soluble total proteins) and the purified yield was more than 30mg/L by one-step purification. Then,the purified AHc was used to vaccinate Balb/c mice,which developed a strong and specific immune response as expected following administration of AHc protein via the subcutaneous route. Results from BoNT/A neutralization assay showed that the serum from mice vaccinated with AHc contained high titer protective antibody. These results showed that the soluble,stable and high-levelly expressive AHc not only could be produced by the prokaryotic expression system built in our lab,but also owned strong immunogenicity to prepare antitoxin for treatment and as sub-unit candidate vaccine for prophylaxis against botulinum toxin serotype A.